Testing effectiveness (Phase 2)Not Yet RecruitingNCT06320951
What this trial is testing
VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway
Who this might be right for
Cardiovascular DiseasesInsulin Sensitivity/ResistanceMetabolic Disease+3 more
University of Alabama at Birmingham 200